New York State Employee Drug Testing: Rights, Cannabis, and EAP

The New York State employee drug testing policy splits workers into two groups: those in safety-sensitive or federally regulated jobs, who face mandatory screening, and everyone else, who generally cannot be tested at random or before hire and whose off-duty cannabis use is protected by state law. The framework pulls from the federal Omnibus Transportation Employee Testing Act, the Drug-Free Workplace Act of 1988, and New York Labor Law Section 201-d, and the group you fall into decides almost every question that follows.

Who Can Be Tested

Testing is targeted, not universal. The state policy identifies the categories of workers subject to screening.¹

Employees who hold a Commercial Driver’s License or operate commercial motor vehicles. These workers fall under the Omnibus Transportation Employee Testing Act of 1991 and get the full federal panel of tests.²
Department of Corrections and Community Supervision staff who regularly handle illegal drugs, including the Office of Special Investigations Narcotics Unit and the K-9 Unit. They are subject to random testing and may be screened first with a saliva test.³
Any position where testing is required by a separate statute, regulation, professional contract, or collective bargaining agreement.

If your job sits outside those categories, the state cannot subject you to pre-employment or random drug tests. The only route to testing is reasonable suspicion that you can’t perform your duties because of alcohol or controlled substance use.

When Tests Can Happen

For employees who are subject to testing, each test has a defined trigger.

Pre-employment. Applicants for safety-sensitive or CDL positions must pass a drug test before starting work. Agencies cannot push this requirement onto general-classification positions unless a law or regulation specifically authorizes it.
Random. DOT-regulated employees sit in a selection pool and can be called for testing at any point in the year with no advance notice. DOCCS narcotics unit and K-9 staff are also tested randomly.³
Reasonable suspicion. A trained supervisor who observes specific signs of impairment can order a test.
Post-accident. After a workplace accident or safety incident, agencies can require immediate testing to see whether substances contributed.
Return-to-duty. An employee being reinstated after a prior violation must test negative before resuming safety-sensitive work.
Follow-up. After return, employees face unannounced tests, starting with at least six in the first twelve months.⁴

What Gets Screened, and Where Cannabis Fits

DOT-regulated testing uses a standardized five-category panel: marijuana metabolites, cocaine metabolites, opioids (including codeine, morphine, hydrocodone, oxycodone, and heroin), amphetamines and methamphetamines (including MDMA), and phencyclidine.⁵ Because prescription opioids are included, a worker with a legitimate prescription for oxycodone or hydrocodone should be ready to disclose that prescription to the Medical Review Officer who reviews any positive result.

Cannabis is where state and federal rules diverge sharply. The Marijuana Regulation and Taxation Act amended Labor Law Section 201-d so that legal cannabis use is treated as a protected off-duty activity. Most state agencies cannot discipline you for using cannabis on your own time, away from work, and without using the employer’s property.⁶

Three exceptions survive. Employers can still act on cannabis when a state or federal law requires it, when the employee shows specific observable symptoms of impairment that reduce performance or threaten safety, or when inaction would violate federal law or jeopardize a federal contract or funding.⁶ For DOT-regulated positions, that first exception swallows the protection. The U.S. Department of Transportation has stated that safety-sensitive transportation employees will continue to be tested for marijuana regardless of state legalization.⁷ Employees working under federal contracts above the simplified acquisition threshold or on federal grants face similar exposure under the Drug-Free Workplace Act.¹

Why a Positive Cannabis Test Alone Is Not Impairment

The New York Department of Labor has made clear that a positive drug test, standing alone, cannot establish cannabis impairment, because current tests detect past use rather than present intoxication.⁸

Impairment has to be shown through “articulable symptoms,” meaning objectively observable signs that job performance has actually dropped or that workplace safety is compromised. The DOL offers one example: operating heavy machinery in an unsafe and reckless manner. Two things that do not qualify on their own are the smell of cannabis and visible signs of use that don’t affect performance.⁸ A supervisor who smells cannabis on an employee’s clothes but sees no performance issue has no legal basis to order a test.

Reasonable Suspicion: What a Supervisor Needs

For controlled substances other than cannabis, supervisors can order testing when they have a reasonable, articulable belief, based on specific and current observations, that an employee is using a prohibited drug. Physical indicators like slurred speech or an unsteady walk, together with behavioral signs like sudden performance problems, can meet the threshold.¹

DOT-regulated employees get an extra layer of protection. At least two supervisors must agree that testing is warranted, and at least one of them must have completed training in recognizing signs of drug use. In agencies with fifty or fewer employees subject to testing, one trained supervisor is enough.⁹ The supervisor’s contemporaneous notes become the legal foundation for the test, and vague entries like “seemed off” won’t survive a challenge.

Your Rights When You’re Tested

Testing begins at a designated collection site. You present government-issued photo identification, give a specimen under protocols meant to prevent tampering while preserving privacy, and the sealed sample goes to a certified laboratory.

Before any result reaches your employer, a Medical Review Officer reviews it. The MRO is a licensed physician who acts as an independent check, verifying positives and considering legitimate medical explanations such as a valid prescription. Only a verified result goes to the agency.¹⁰

The 72-Hour Split Specimen Request

If you receive a verified positive result from DOT-regulated testing, you have the right to request that a split portion of your specimen be tested at a second certified laboratory. You have 72 hours from the MRO’s notification to make the request, and it can be made verbally or in writing.¹¹

Missing the deadline is not automatically fatal. Serious illness, lack of actual notice, inability to reach the MRO, or other unavoidable circumstances can justify a late request if you document them for the MRO, who may still order the split specimen test. Once a timely request is made, the MRO must direct the original lab to forward the split specimen to a different certified lab right away.¹¹ This specific right applies to DOT-regulated testing; employees covered only by the state’s general workplace policy should check their collective bargaining agreement for analogous protections.

Union Representation

Most state employees are covered by collective bargaining agreements, and the contract often matters more than statute when discipline is on the table. When a test is ordered as part of an investigation into suspected misconduct, unionized employees generally have the right to consult with a union representative before consenting. Random and pre-employment tests are not investigatory and usually don’t trigger representation rights.

The specifics vary by bargaining unit. Employees covered by PEF, CSEA, or other state unions should review their contract’s drug-testing, disciplinary, and grievance provisions. The union contract often decides whether a positive leads to termination, a last-chance agreement, or a mandated treatment program. Contact your union steward before responding to any disciplinary proposal.

What a Positive Test or Refusal Costs

For DOT-regulated employees, a confirmed positive or a refusal to test triggers immediate removal from safety-sensitive duties. Federal rules treat a refusal the same as a positive. You cannot return to safety-sensitive work until you complete the full return-to-duty process with a qualified Substance Abuse Professional.¹²

For DOCCS employees, refusing an ordered test or refusing to cooperate with the testing procedure can result in suspension and formal disciplinary charges under the applicable collective bargaining agreement.³

Employees working under federal contracts carry a separate reporting duty: a criminal drug conviction for conduct that occurred in the workplace must be reported to the agency within five days.¹

Specific disciplinary outcomes beyond removal from duty depend on the agency and bargaining unit. The range of penalties, the grievance timeline, and whether a last-chance agreement is available all live in the contract between the state and the union.

The Return-to-Duty Path

A violation does not mean automatic termination. Federal regulations lay out a structured path back, built around a Substance Abuse Professional. The SAP is a licensed or certified clinician who evaluates the employee, prescribes education or treatment, and later confirms whether the employee has followed through. The SAP’s job is public safety; they do not advocate for either side.¹³

The sequence runs in stages. The SAP conducts a clinical evaluation and recommends treatment or education. You complete it. The SAP conducts a follow-up evaluation to confirm successful compliance. Only then can your employer arrange a return-to-duty test, which must come back negative before you can resume safety-sensitive work.⁴

After you return, expect at least six unannounced follow-up tests in the first twelve months. The SAP can require more than six if clinically warranted and can extend follow-up testing beyond that first year.⁴

Federal rules create the pathway. Whether the employer actually puts you back on the schedule is a separate decision, governed by the contract and by whatever protections your bargaining agreement provides.

Voluntary Treatment and the EAP

New York’s Human Rights Law protects employees who are recovering or recovered from drug or alcohol addiction, provided they are not currently using illegal drugs. Covered employers must make reasonable accommodations, such as scheduling adjustments for ongoing treatment, as long as the employee can perform the essential functions of the job.

Timing changes the outcome. An employee who enters treatment before the agency starts disciplinary action is in a far better position than one who seeks help only after a positive test. The state’s Employee Assistance Program offers confidential referrals, counseling, and help with insurance and treatment options, and reaching out before a problem shows up in a test can save a career. The state policy also permits the use of properly prescribed medication, including medical cannabis in accordance with state law, at work locations where it is allowed.¹

1
SUNY. New York State Alcohol and Controlled Substances Policy
2
Federal Motor Carrier Safety Administration. Overview of Drug and Alcohol Rules for Employers
3
New York State Department of Corrections and Community Supervision. Directive 2115 – Drug Tests for Employees
4
eCFR. 49 CFR Part 40 Subpart O – Substance Abuse Professionals and the Return-to-Duty Process
5
eCFR. 49 CFR 40.85
6
New York State Senate. New York Labor Law 201-D – Discrimination Against the Engagement in Certain Activities
7
US Department of Transportation. DOT Notice on Testing for Marijuana
8
New York State Department of Labor. Adult Use Cannabis and the Workplace
9
New York Codes, Rules and Regulations. 16 CRR-NY 262.105 – Drug Tests Required
10
US Department of Transportation. Medical Review Officers
11
eCFR. 49 CFR 40.171
12
Federal Motor Carrier Safety Administration. What if I Fail or Refuse a Test
13
US Department of Transportation. Substance Abuse Professionals